Overview

The Passy-Muir Speaking Valve (PMV) is a one-way airflow valve designed for patients with a tracheostomy tube. It opens on inhalation to allow air into the lungs, then closes on exhalation, redirecting airflow upward through the vocal cords, pharynx, and mouth. This restored airflow pattern has profound implications not only for voice production but for swallowing safety — making it a critical piece of equipment in the dysphagia management of tracheostomised patients.

How the Valve Works

A standard tracheostomy tube creates an open column between the trachea and the outside air. During exhalation, air exits through the trach tube rather than flowing through the upper airway. This disrupts the normal subglottic air pressure that aids vocal cord closure and contributes to protective swallowing reflexes.

The PMV’s closed-position spring mechanism restores translaryngeal airflow on exhalation. Key physiological consequences:

Dysphagia-Specific Benefits

Tracheostomised patients face several swallowing challenges not seen in the general dysphagia population:

  1. Reduced laryngeal elevation — the trach tube can tether laryngeal movement, impairing the upward excursion needed to close the airway during swallowing.
  2. Blunted sensation — absence of airflow through the larynx dulls sensory feedback, reducing the protective response to penetration.
  3. Impaired cough — without translaryngeal airflow, the expulsive force of a cough is diminished.
  4. Disrupted swallowing–breathing coordination — normal swallowing relies on a brief apnoea; the open trach tube changes this timing.

PMV use addresses several of these issues simultaneously. Clinical evidence suggests that patients placed on a PMV trial show improvements in swallowing safety scores on instrumental assessments such as videofluoroscopic swallowing study (VFSS) and flexible endoscopic evaluation of swallowing (FEES).

Candidacy Criteria

Not all tracheostomised patients are appropriate PMV candidates. The following criteria should be met before trialling:

Inclusion indicators:

Key assessment step — cuff deflation trial: Before any PMV can be placed, the tracheostomy cuff must be deflated. Patients who cannot maintain oxygen saturation or respiratory rate during cuff deflation are not yet candidates for PMV.

Contraindications

Contraindication Reason
Inflated tracheostomy cuff during valve use No expiratory airflow path — risk of asphyxiation
Severe upper airway obstruction Cannot exhale around trach tube
Copious secretions risking valve occlusion Valve may block
Severe respiratory compromise Increased expiratory resistance may be unsafe
Unconscious or uncooperative patient Cannot monitor response
Foam-cuffed tracheostomy tube Cuff cannot be fully deflated

Note: The PMV is designed for use only with the cuff deflated. This is non-negotiable and the most common cause of critical incidents involving the valve.

Who Places the Valve? Multidisciplinary Roles

PMV placement is inherently a multidisciplinary procedure in most Hong Kong public hospitals and rehabilitation centres:

SLPs in Hong Kong working in the Hospital Authority system typically follow a standardised protocol for PMV introduction, often beginning with short supervised trials of 15–30 minutes.

Wearing Schedule and Weaning

Introduce the PMV gradually:

  1. Initial trial — 15–30 minutes with SpO2 monitoring and clinician present.
  2. Gradual increase — extend wearing time in increments as tolerated.
  3. Unsupervised wear — only after the patient demonstrates reliable tolerance and appropriate cognition.
  4. Wearing during meals — wearing the PMV during eating and drinking (once safe) supports swallowing efficiency.
  5. Night use — not typically recommended without specific clinical indication and monitoring.

Swallowing Assessment with PMV In Situ

Where resources permit, swallowing function should be assessed instrumentally both with and without the PMV. Some patients show significantly better swallowing on FEES or VFSS with the valve in place, reinforcing the case for its continued use. Others show little difference, which informs the clinical decision about how much emphasis to place on PMV in the overall rehabilitation plan.

Cleaning and Safety

Hong Kong Context

PMV is available through:

Summary

The Passy-Muir Speaking Valve is far more than a voice restoration device. By restoring translaryngeal airflow, it directly supports the sensory and motor components of safe swallowing in tracheostomised patients. Careful patient selection, mandatory cuff deflation, multidisciplinary coordination, and gradual introduction are the cornerstones of safe and effective PMV use. For speech-language pathologists managing dysphagia in this population, the PMV is often an indispensable clinical tool.